Muscle News and Research

RSS

NIH $1 million Challenge Grant to refine cell-tracking nanotube technology

The National Institutes of Health (NIH) has awarded researchers at Rice University and the Texas Heart® Institute (THI) a $1 million Challenge Grant to refine cell-tracking nanotube technology that could make magnetic resonance imaging (MRI) up to 40 times more sensitive than existing MRIs and help guide adult stem cells within the human body to repair damaged hearts.

10 Nov 2009

Prostatitis is a psychoneuromuscular condition: Study

In the November 2009 issue of the Journal of Urology, Stanford Medical School researcher Dr. Rodney Anderson and researchers at the National Center for Pelvic Pain Research, in a new study, demonstrated a high correlation between the location of painful trigger points inside the pelvic floor muscles of men with chronic prostatitis and the location in the body where they routinely complain of pain.

10 Nov 2009

Individuals with weaker muscles face higher risk for Alzheimer's disease

Individuals with weaker muscles appear to have a higher risk for Alzheimer's disease and declines in cognitive function over time, according to a report in the November issue of Archives of Neurology, one of the JAMA/Archives journals.

10 Nov 2009

UOHI to receive $5.4M federal funds for development of new alternative radioisotope imaging tracers

Researchers from the University of Ottawa Heart Institute (UOHI) will receive nearly half of a $5.4 million federal fund to help solve a shortage of medical isotopes resulting from the shutdown of the Chalk River nuclear reactor. Two research teams will develop two new alternative radioisotope imaging tracers, test new applications for their use in diagnosing heart disease, and fast track production and distribution as quickly as possible across Canada.

10 Nov 2009

GTx reports financial results for the third quarter of 2009

GTx, Inc. today reported financial results for the third quarter of 2009. The net loss for the third quarter and nine months ended September 30, 2009 was $12.8 million and $35.4 million, respectively, compared with a net loss of $11.9 million and $37.9 million for the same periods in 2008. At September 30, 2009 GTx had cash, cash equivalents and short-term investments of $55.5 million.

9 Nov 2009

Renewal Laboratories to produce functional beverages with anti-oxidants and omega3 fatty acids

Renewal Laboratories announced today that it has developed a patent pending process to produce functional beverages with important anti-oxidants and omega3 fatty acids. Natural, nutritionally important supplements such as Coenzyme Q10, resveratrol, and omega3 fish oil may now be offered in appealing and refreshing drinks.

9 Nov 2009

Pain management physician offers house calls to residents of Manhattan in New York City

Davis Bregman, a pain management physician will now offer routine house calls to residents of Manhattan in New York City. Patients will be able to request a house call by calling the office at 212-918-1629 or sending an email from davisbregman.com.

9 Nov 2009

Health education on ID and stability balls, an opportunity for healthier life

An Indiana University study involving adults with intellectual disabilities found that the adults increased their personal health knowledge after taking a semi-weekly class for four weeks.

9 Nov 2009

Specialization in one sport increases the risk of injury, find researchers

Gifted young athletes are under increasing pressure to play only one sport year round.

9 Nov 2009

Researchers find compound that reverses type 1 myotonic dystrophy

A compound already used to treat pneumonia could become a new therapy for an inherited muscular wasting disease, according to researchers at the University of Oregon and the University of Rochester School of Medicine and Dentistry in New York.

7 Nov 2009

PPMD awards $75,000 grant to University of California professor for Duchenne muscular dystrophy research

Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today the latest recipient of the End Duchenne Grant Award Program.

6 Nov 2009

Bioniche Life Sciences announces financial results for its Fiscal 2010 first-quarter

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its Fiscal 2010 first quarter, ended September 30, 2009.

6 Nov 2009

Research reveals new biological function of polycystins in regulating pressure sensing

What is the role of proteins called polycystins in patients with polycystic kidney disease? A team of researchers from CNRS and INSERM, led by Eric Honoré from the Institut de Pharmacologie Moléculaire et Cellulaire (IPMC, Université de Nice Sophia Antipolis/CNRS) has elucidated the molecular and cellular mechanisms linked to polycystin malfunctions that cause this common hereditary disease.

6 Nov 2009

Understanding how regulatory networks drive development

Embryonic development is like a well-organised building project, with the embryo's DNA serving as the blueprint from which all construction details are derived. Cells carry out different functions according to a developmental plan, by expressing, i.e. turning on, different combinations of genes.

6 Nov 2009

Scientists identify a novel cellular source of atrial fibrillation

While studying how the heart is formed, scientists at the University of Pennsylvania School of Medicine serendipitously found a novel cellular source of atrial fibrillation (AF), the most common type of abnormal heart beat.

5 Nov 2009

Tetracycline-like compound raises hope for treatment of spinal muscular atrophy

A chemical cousin of the common antibiotic tetracycline might be useful in treating spinal muscular atrophy (SMA), a currently incurable disease that is the leading genetic cause of death in infants. This is the finding of a research collaboration involving Adrian Krainer, Ph.D., of Cold Spring Harbor Laboratory (CSHL) and scientists from Paratek Pharmaceuticals and Rosalind Franklin University of Medicine and Science.

5 Nov 2009

Statins may have negative effects on some cardiac patients, says study

Although statins are widely used to prevent heart attacks, strokes, and other cardiovascular disorders, new research shows that the class of drugs may actually have negative effects on some cardiac patients. A new study presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), found that statins have beneficial effects on patients with systolic heart failure (SHF), but those with diastolic heart failure (DHF) experienced the opposite effect, including increased dyspnea, fatigue, and decreased exercise tolerance.

4 Nov 2009

Acceleron Pharma commences Phase 1 clinical study of its novel angiogenesis inhibitor

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced the initiation of a Phase 1 clinical study of ACE-041, a novel angiogenesis inhibitor that binds to and prevents members of the TGF-β superfamily from signaling through the activin receptor-like kinase 1 (ALK1) receptor.

4 Nov 2009

Muscle Flex to release Beagle StepFit 2-minute direct response commercial with BUDDY Tablet Caddy

Muscle Flex Inc. (www.MuscleFlexInc.com) announced today that it has released the Muscle Flex® Beagle StepFit™ 2-minute commercial and one-page landing page at www.BuyTheBeagle.com.

4 Nov 2009

International Omega-3 Awareness Day to educate public about proven health benefits of omega-3

Scientific evidence of the health benefits of omega-3's are now so firmly established that omega-3 expert Carol A. Locke, MD, with a team of world-renowned doctors, has spearheaded the first ever International Omega-3 Awareness Day on March 3rd, 2010. Learn more at www.Omega3Day.com.

4 Nov 2009

Muscle News and Research

NIH $1 million Challenge Grant to refine cell-tracking nanotube technology

Prostatitis is a psychoneuromuscular condition: Study

Individuals with weaker muscles face higher risk for Alzheimer's disease

UOHI to receive $5.4M federal funds for development of new alternative radioisotope imaging tracers

GTx reports financial results for the third quarter of 2009

Renewal Laboratories to produce functional beverages with anti-oxidants and omega3 fatty acids

Pain management physician offers house calls to residents of Manhattan in New York City

Health education on ID and stability balls, an opportunity for healthier life

Specialization in one sport increases the risk of injury, find researchers

Researchers find compound that reverses type 1 myotonic dystrophy

PPMD awards $75,000 grant to University of California professor for Duchenne muscular dystrophy research

Bioniche Life Sciences announces financial results for its Fiscal 2010 first-quarter

Research reveals new biological function of polycystins in regulating pressure sensing

Understanding how regulatory networks drive development

Scientists identify a novel cellular source of atrial fibrillation

Tetracycline-like compound raises hope for treatment of spinal muscular atrophy

Statins may have negative effects on some cardiac patients, says study

Acceleron Pharma commences Phase 1 clinical study of its novel angiogenesis inhibitor

Muscle Flex to release Beagle StepFit 2-minute direct response commercial with BUDDY Tablet Caddy

International Omega-3 Awareness Day to educate public about proven health benefits of omega-3

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News